Cartesian Therapeutics Inc. (RNAC)
NASDAQ · Healthcare
Cartesian Therapeutics Inc. Total Liabilities 2014–2025
Cartesian Therapeutics Inc. annual/quarterly total liabilities history from 2015 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Cartesian Therapeutics Inc. total liabilities for the quarter ending December 31, 2025 were 422.7M, a 4.34% decrease year-over-year.
- Cartesian Therapeutics Inc. total liabilities for 2025 were 422.7M, a 4.34% decrease from 2024.
- Cartesian Therapeutics Inc. total liabilities for 2024 were 441.8M, a 0.64% decrease from 2023.
- Cartesian Therapeutics Inc. total liabilities for 2023 were 444.7M, a 517.11% increase from 2022.
- Cartesian Therapeutics Inc. total liabilities for 2022 were 72.1M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Cartesian Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $423 |
| 2024 | $442 |
| 2023 | $445 |
| 2022 | $72 |
| 2021 | $137 |
| 2020 | $183 |
| 2019 | $91 |
| 2018 | $50 |
| 2017 | $49 |
| 2016 | $34 |
| 2015 | $22 |
| Cartesian Therapeutics Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $423 |
| 2024-12-31 | $442 |
| 2023-12-31 | $445 |
| 2022-12-31 | $72 |
| 2021-12-31 | $137 |
| 2020-12-31 | $183 |
| 2019-12-31 | $91 |
| 2018-12-31 | $50 |
| 2017-12-31 | $49 |
| 2016-12-31 | $34 |
| 2015-12-31 | $22 |
Cartesian Therapeutics Inc. Total Liabilities — FAQ
Cartesian Therapeutics Inc. (RNAC) total liabilities over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RNAC's total liabilities history?
The chart and table above show Cartesian Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.